Here You Would Find Why Avenue Therapeutics, Inc. (ATXI) Stock is on a Continuous Rally
Avenue Therapeutics, Inc. (ATXI), a specialty pharmaceutical company, has declined 5.29% in aftermarket trading session. Consequently, ATXI stock is trading at $1.61 at the time of